Differential display methodology was employed to examine and compare the mRNA species derived from normal endometrial tissue and endometrial carcinoma (grade 3, stage III) tissue biopsies. Two cDNA sequences, one expressed in the tumour group only (T19) and the other expressed only in the normal group (N22), were selected for verification of differential expression by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). The expression of N22 was restricted to the normal group, suggesting a possible tumour suppressing function. Sequence analysis of this fragment revealed a high degree of similarity to a human cDNA sequence of unknown function. The expression of T19 mRNA was observed in both normal and neoplastic tissues, however the relative abundance was significantly higher in endometrial carcinomas. Expression of T19 mRNA was further examined in a larger clinical sample set and was significantly increased in the tumours (n ⍧ 16), with a three-fold increase when compared with the normal endometria, n ⍧ 5 (Kruskal-Wallis analysis of variance, P < 0.05). Subsequent sequence analysis of T19 revealed a high degree of similarity to the 3Ј untranslated region of a rat growth factor responsive gene, SM-20. Further characterization of these mRNA transcripts may lead to the identification of novel genes involved in endometrial tumourogenesis.
Introduction
cancer (Potischman et al., 1996; Weiderpass et al., 1999) . During the initial stages of the multi-step process of cancer Carcinoma of the endometrium is the most commonly development in the endometrium, tumour growth may be diagnosed invasive cancer of the female reproductive tract, dependent on oestrogen stimulation, however with neoplastic with the most common clinical presentation of disease being evolution, through the loss of functional oestrogen receptors post-menopausal bleeding or irregular bleeding. The standard or the uncoupling of receptor and hormone complexes, the treatment for endometrial carcinoma is abdominal hysterectumours may become hormone independent. Therefore, while tomy and bilateral salpingo-oophorectomy (Magrina et al., oestrogen is known to be a major promoter of tumour growth 1999) and a combination of radiotherapy (Jereczek-Fossa et al., in the early stages of endometrial cancer, the underlying 1999), chemotherapy (Gabriele et al., 1998) and hormone molecular genetic alterations that are essential for the progrestherapy (Lhomme et al., 1999) are often used adjunctively to sion to malignant and metastatic disease are still unknown. surgery. At present, there is no effective early detection Changes at the DNA level, such as nucleotide base pair screening method for endometrial cancers. The use of gynaecomutations, gene amplifications, chromosome translocations and logical malignancy markers, e.g. and preventative deletions are common events that occur in the evolution of screening tests, e.g. Papanicolou smears, are often unsuccessful other cancers. The development of cancer depends on the in detecting early stage endometrial carcinoma as they are occurrence of these events in genes that govern cell growth specifically aimed at the early detection of ovarian and cervical regulation, proteolytic degradation and angiogenesis, ultimately cancers (Berchuck et al., 1995; Westof et al., 1997) . Diagnostic leading to the expression of a non-functional protein or to an and prognostic markers specific to this disease are few, with alteration in the level of mRNA and subsequent protein the depth of myometrial invasion and degree of metastasis, expression of these genes. differentiation type and hormone receptor status commonly
In an attempt to resolve the mechanisms involved in the used as prognostic markers and guides to treatment.
progression from a normal to a neoplastic state, earlier studies Despite the prevalence of endometrial cancer, little is known have examined the association between endometrial carcinoma of the molecular factors that contribute to the development and previously described tumour suppressor genes and oncoand evolution of the neoplastic process in the endometrium.
genes originally isolated in other forms of cancer. The expresThe growth factor-like effects of oestrogen on the endometrium are believed to play an important part in the promotion of this sion of the tumour suppressor gene, p53, was commonly altered in endometrial carcinomas and has been shown to be RT-PCR et al., 1996; Geisler et al., 1999) . The role of genes, Her/neu-2
Primer no. Primer sequence (Hetzel et al., 1992) , epidermal growth factor receptor (EGFR) (Scambia et al., 1993) , ras p21 (Scambia et al., 1994) and c-fos, HT 11 G (oligo dT) AAAGCTTTTTTTTTTTG c-jun, c-myc (Yokoyama et al., 1998) transcription was performed at 37°C for 1 h, after which the enzyme from participating patients. Clinical specimens were obtained (prior was inactivated by heating the reactions to 75°C for 5 min. Subsequent to any treatment) at the time of surgery from pre-menopausal and cDNA amplification by PCR was performed in a 20 µl reaction post-menopausal women undergoing abdominal hysterectomy and containing one tenth of a reverse transcription reaction, 0.2 µmol/l bilateral salpingo-oophorectomy for gynaecological malignancies.
each of an arbitrary sequence primer (Table I ) and the anchored oligo Normal samples were obtained either by dilatation and curette or dT primer used in the RT reaction, 2 µl PCR buffer (100 mmol/l biopsies were excised from women undergoing hysterectomy for Tris-Cl, pH 8.4, 500 mmol/l KCl, 15 mmol/l MgCl 2, and 0.01% other gynaecological malignancies. These samples were deemed gelatin), 2 µmol/l dNTP, 0.3 µl [α-35 S]-dATP (1200 Ci/mmol, normal by both gross and microscopic pathology. Samples obtained Amersham, UK), 1 IU AmpliTaq DNA polymerase (Perkin Elmer). from patients prescribed hormone modulation medication (contraceptCycle conditions were as follows; 95°C for 15 s, 40°C for 30 s and ives or hormone replacement therapy) or tamoxifen, were excluded 72°C for 1 min for 40 cycles, followed by 72°C for 5 min. from this study. The samples were snap-frozen in liquid nitrogen and Thermocycling was performed with an Omni-E Thermocycler stored at -80°C. For the initial differential display mRNA analysis, (Hybaid, UK). The PCR products were size fractionated by electrothree normal endometrial samples (proliferative phase n ϭ 1, secretory phoresis on a 6% denaturing polyacrylamide gel in 1ϫ Tris/borate/ phase n ϭ 2) were obtained from pre-menopausal patients and three EDTA (TBE) buffer. Of each PCR 15% were loaded onto the gel. endometrial adenocarcinomas were obtained from post-menopausal Following electrophoresis the gels were blotted on a piece of 3MM (n ϭ 2) and pre-menopausal patients (n ϭ 1). These carcinomas were paper, dried under vacuum and overlaid with X-ray film overnight. classified using the FIGO (International Federation of Gynecology and Obstetrics) classification as grade 3, stage IIIa endometrioid
Single stranded conformation polymorphism analysis carcinomas. The remaining tissue samples used in the semi-quantitat-(SSCP) ive RT-PCR analysis were derived from normal endometria (proliferGel slices containing cDNA amplicons that were expressed in all ative endometria, n ϭ 3, secretory endometria, n ϭ 2) and from three RNA samples in either the normal or carcinoma groups were endometrial carcinomas derived from pre-menopausal endometrium excised from the polyacrylamide gel. The corresponding region of (proliferative phase, n ϭ 4) and post-menopausal endometrium the gel, which did not contain the band, was also excised. The DNA (n ϭ 12). The carcinomas were grouped on the basis of grade of was extracted from the gel debris by soaking in 100 µl of H 2 O for differentiation; grade 1 (well-differentiated, n ϭ 4), grade 2 (moder-10 min followed by boiling for 15 min. Glycogen (50 µg) was then ately-differentiated, n ϭ 6), grade 3 (poorly-differentiated, n ϭ 6).
added to facilitate precipitation with ethanol. The precipitated DNA (2 µl) was used in a PCR containing, 20 RNA isolation and preparation µmol/l dNTP, PCR buffer (100 mmol/l Tris-Cl, 500 mmol/l KCl and 15 mmol/l MgCl 2 ), 0.1 µl [α 32 P]-dCTP (3000 Ci/mmol), 2 IU Total RNA was extracted from frozen tissue biopsies as described previously (Chirgwin et al., 1979) . The RNA was incubated with AmpliTaq DNA polymerase, and the appropriate primer pair (0.2 at which PCR product amount was optimal and within the linear To confirm the sequence composition of RT-PCR products, specific GAPDH 5Ј-GAA ATC CCA TCA CCA TCT TCC-3Ј S probes were isolated from the three recombinant plasmids containing 5Ј-CCA GGG GTC TTA CTC CTT GG-3Ј AS 805 bp N22, T19 and GAPDH, by restriction enzyme digestion with EcoRI and SacI (Boehringer Mannheim) and purification from agarose gel µmol/l) to a final volume of 20 µl. The cycle conditions were as after electrophoresis. The cDNA was excised and purified from the follows; 94°C for 30 s, 40°C for 30 s and 72°C for 1 min, for agarose gel using a DNA purification resin column (Promega, 22 cycles, followed by 5 min at 72°C. The PCR products were Wisconsin, USA). The cDNA was labelled with 5 µl of [α-32 P]-electrophoretically separated on a 6% acrylamide gel containing dCTP, 3000 Ci/mmol (Amersham, UK) in a 50 µl reaction containing 10% glycerol. The products were mixed with 18 µl of loading dye 250 mmol/l Tris-HCl, pH 8.0; 25 mmol/l MgCl 2 , 10 mmol/l DTT, 1 (90% formamide, 0.05% Bromophenol Blue, 0.05% xylene cyanol, mol/l HEPES, pH 6.6 and 1 IU of DNA polymerase 1, Large (Klenow) 5 mmol/l EDTA), heated to 95°C for 3 min and loaded onto the gel. fragment (Promega). The cDNA was then used as a probe to confirm The gel was run in 1ϫ TBE buffer at 8 W for 18 h. The gel was the specificity of the RT-PCR by Southern blot analysis. then blotted on 3MM paper, dried under vacuum and overlaid with Biomax film (Kodak) for 24 h. Differentially expressed bands verified Southern blot analysis by SSCP analysis were then excised from the gel and were each PCR products (10% of final PCR volume) were resolved on 2% separately cloned into PCRscript™ plasmid (Stratagene, La Jolla, agarose gels prepared in 1ϫ TAE (0.04 M Tris-acetate, 0.001 M USA).
EDTA, pH 8.0) buffer alongside pGEM DNA markers (Promega) to confirm PCR product sizes. The gels were prepared for Southern Sequence analysis transfer by sequential soaking in 0.5 mol/l NaOH/1.5 mol/l NaCl Recombinant plasmids containing amplicon inserts were purified solution for 40 min and 1 mol/l Tris/1.5 mol/l NaCl for 40 min. The (High pure plasmid isolation kit, Boehringer Mannheim) and amplicons were transferred to Hybond-N membrane by capillary subsequently sequenced using a PE Applied Biosystems 377 blotting with 20ϫ sodium chloride/sodium citrate (SSC) and were DNA sequencer and a Dye terminator reaction kit (Perkin Elmer, immobilized by UV cross-linking. Membranes were incubated for Norwalk, USA). Sequence databases available at WEBANGIS (http:// 1 h at 42°C in hybridization buffer [50% formamide, 6ϫ SSPE www.webangis.org.au) were searched using the BLASTn program to (0.84 M NaCl, 0.048 M NaH 2 PO 4 ·H 2 O, 0.006 M EDTA, pH 7.4), check the cloned cDNA sequences for any similarity to previously 0.5% sodium dodecyl sulphate (SDS), 5ϫ Denhardt's solution (0.1% characterized genes.
bovine serum albumin, 0.1% Ficoll, 0.1% polyvinylpyrrolidene and 0.025% skimmed milk powder] and then hybridized with the radioSemi-quantitative RT-PCR labelled probe overnight at 42°C. The membranes were washed in RT-PCR was performed using Titan™ One Tube RT PCR system 1ϫ SSC/0.1% SDS at 42°C for 15 min followed by 0.1ϫ SSC/0.1% (Boehringer Mannheim). In one tube the following reagents were SDS at 55°C for 15 min. The membranes were overlaid with Kodak added; 0.4 µmol/l of forward and reverse primer [specific primers XOMAT-AR film for 2 h. The autoradiograms were scanned and the for each of the two putative mRNA transcripts, N22 and T19 (Table  PCR products were quantified using laser densitometry (Molecular II) and also for the housekeeping gene GAPDH], 0.2 mmol/l dNTPs, Dynamics, USA). For semi-quantitative analysis, the intensity of 5 mmol/l DTT, 10 IU RNAse Inhibitor (Promega), 10 µl of 5ϫ RThybridization signal for either N22 or T19 amplicons was expressed PCR buffer, 1.5 mmol/l MgCl 2 and 1 µl of enzyme mix (Expand™ as a ratio of a positive control on the membrane and was normalized High Fidelity enzyme mix, reverse transcriptase, AMV). Finally, total against the GAPDH amplicon signal. RNA was added to each reaction, which was either 750 ng of total RNA (for N22 semi-quantitative RT-PCR) or 500 ng (for T19
Statistical analysis semi-quantitative PCR analysis). Primer sequences (Table II) were
The data were analysed for homogeneity of variance using Levene's determined using PRIMER software available at WEBANGIS (http:// test. Non-parametric statistical tests (Kruskal-Wallis analysis of www.angis.org.au). Thermocycling (RT and PCR) was performed in variance and Mann-Whitney U-test) were used to analyse nona single tube with an Omni-E Thermocycler (Hybaid, UK) using a homogenous data. P Ͻ 0.05 was considered to be statistically high stringency thermal profile which consisted of 50°C for 30 min significant. and 94°C for 5 min (reverse transcription and RT inactivation), followed, for the N22 PCR cycle; 94°C for 30 s, 55.6°C for 30 s and 68°C for 45 s for 10 cycles; 94°C for 30 s, 55.6°C for 30 s and 68°C
Results
for 50 s for 10 cycles; 94°C for 30 s, 55.6°C for 30 s and 68°C for 55 s for nine cycles (GAPDH) or 13 cycles (N22). The annealing
Selection of differentially expressed mRNAs by
temperature used in the T19 PCR was 49.3°C; the cycle number and differential display profile was otherwise identical to that used for the N22 PCR. Cycle
The mRNA expression pattern derived from three normal number was determined by the establishment of a standard curve of endometrial tissues and three endometrial carcinoma tissues PCR product amount versus PCR cycle number for N22, T19 and GAPDH PCR. The cycle number chosen was deemed to be the point was compared using differential display RT-PCR methodology from RNA fingerprinting gels was successful in separating cDNAs of similar size, since each cDNA species had a distinct mobility pattern on a SSCP gel due to the difference in (Figure 1) . From a total of 24 primer pair combinations, the most informative primer pair combinations contained H-T 11 G sequence composition (Figure 2a,b) . From~24 cDNA bands excised from fingerprinting gels, only four cDNA bands showed as the anchored primer. PCRs using H-T 11 G as one of the primers, produced the highest number of cDNA species and reproducible differences and were selected for further analysis. also the most differentially expressed cDNA bands. Primers Semi-quantitative RT-PCR analysis H-T 11 C and H-T 11 A were far less informative. On averagẽ 200 cDNA bands were generated from each primer-pair The four cDNA species selected for further analysis were cloned and sequenced. These cloned cDNA sequences were combination, therefore an estimated 4800 cDNA bands were visualized by differential display RT-PCR. The cDNA bands purified from their respective plasmid vectors, radiolabelled and then hybridized to nylon membranes containing total RNA that were consistently over-expressed or absent in all three samples from only one of either the normal or carcinoma derived from the original normal endometria and endometrial carcinoma samples. Northern blot analysis results indicated groups were considered differentially expressed. The cDNAs were classified as differentially amplified by visual inspection two of the four cDNAs were not differentially expressed and the remaining two cDNA probe hybridizations (N22 and T19) of the sequencing gels. Using these selection criteria~24 cDNA bands, which were differentially amplified, were excised produced ambiguous results. These two putative mRNA species were either not detectable (N22) or produced only very faint from the RNA fingerprinting gels for further analysis. From these 24 cDNAs, 22 cDNAs were derived from PCRs conhybridization signals (T19) by Northern blot analysis. These results highlighted the lack of sensitivity of Northern blot taining the H-T 11 G anchored primer. The most informative forward primers (arbitrary sequence primers) which produced analysis for detecting low abundance messages and therefore led to the adaptation of semi-quantitative RT-PCR analysis of the most differentially amplified cDNA bands, as determined by differential display RT-PCR analysis, were H-AP-3, Hthese two cDNAs isolated by differential display. Expression of T19 (represented by a 190 bp fragment AP-4 and H-AP-7.
Following excision of differentially expressed cDNA bands generated by semi-quantitative RT-PCR analysis), while present in all of the normal (n ϭ 3) and carcinoma samples (n ϭ from differential display RT-PCR gels, the fragments were reamplified using the same primer pair used in the original RT-3), was significantly higher in the tumour group (Figure 3a) . A 229 bp cDNA band generated by semi-quantitative RT-PCR. The fragments excised from the fingerprinting gels often contained a mixture of cDNAs of similar size. To overcome PCR, Figure 3b , and representing N22 was visible in the normal RNA samples examined (n ϭ 3) and absent from the the problem of isolating a contaminated mixture of cDNA fragments, the gel portions containing the differentially amplitumour RNA samples (n ϭ 3). The cDNA, T19, was selected for further analysis in a larger clinical sample set. T19 mRNA fied product and also the corresponding regions where it was not visible (Figure 1a,b) were re-amplified in a radio-labelled expression was observed in all of the RNA samples examined (normal endometria and endometrial carcinomas). Again, PCR and these products were electrophoretically fractionated Figure 5 . Relative abundance of T19 mRNA in normal endometrial and endometrial carcinoma tissues. Expression of T19 in each histological tumour grade was significantly higher than that observed in the normal group (Mann-Whitney U-test, *P Ͻ 0.05). No significant difference in T19 mRNA expression was observed between each tumour grade (grade 1, n ϭ 4; grade 2, n ϭ 6; grade 3, n ϭ 9). Data are expressed as median values with the 25 and 75% quartiles. P Ͻ 0.01) however no significant difference was observed between normal proliferative and secretory samples. of T19 with an EST Genbank database showed a 100% Sequence characterization sequence identity with a human mRNA partial sequence (accession no. gbAA148573), isolated from a pregnant uterus The cDNA fragments T19 and N22 were cloned and sequenced, and the results of each are listed in Table III (T19) and Table  ( over 270 nucleotides). The N22 (425 bp) sequence analysis and comparison with the EMBL (European Molecular Biology IV (N22). The sequence analysis and comparison to EMBL and Genbank databases of T19 (270 bp) revealed 75% sequence Laboratory) and GenBank sequence databases showed an extremely high degree of similarity at the nucleotide level identity at the nucleotide level (Ͼ130 nucleotides) to the 3Ј untranslated region of a growth factor responsive gene isolated (~95% over 356 nucleotides) to a human partial cDNA sequence of unknown function (accession no. gbH60694). from Rattus norvegicus (accession no. gbU06713). Comparison cells of the rat upon exposure to growth agonists, platelet- 
Discussion
quantitative RT-PCR, was clearly restricted to the normal endometrial RNA samples, which was consistent with its From an estimated 100 000 genes in the human genome, 15 000 are expressed in any given cell type at any one time expression on the RNA fingerprinting gel. This alteration in the level of N22 expression in tumour tissues may be the result (Liang and Pardee, 1992) . In this study, almost one third of this number of mRNAs derived from either normal endometrial of molecular genetic changes associated with the development of endometrial cancer. Considering the small sample size tissues or endometrial carcinomas were displayed as cDNA bands on fingerprinting gels. Commonly, when employing examined, it is also difficult to conclude whether the loss of N22 expression in the three tumours examined is a common differential display RT-PCR as a means to identify differentially expressed mRNAs, a large proportion of the differentially event in endometrial tumourigenesis or is restricted to this small sample set. The partial sequence characterization of N22 amplified cDNA species are subsequently found not to be differentially expressed (Liang et al., 1993) . This is thought has given no further suggestions as to the potential function of the putative protein encoded by the mRNA transcript. to be caused in part by slight variations in RNA quantity and quality or from separate reactions causing preferential PCR Comparison of N22 with the sequence databases EMBL and GenBank revealed a 95% sequence identity with a human amplification of cDNAs, which are not actually differentially expressed. In this context, it is not surprising that only two of cDNA clone of unknown function. It is, therefore, impossible to speculate on the putative role of N22 in endometrial the 24 differentially amplified cDNAs identified in this study (designated N22 and T19) , were subsequently shown to be tumourogenesis, although further sequence isolation and characterization of this transcript may reveal a gene encoding a derived from transcripts differentially expressed in normal endometrium and endometrial carcinoma respectively. protein with potential tumour suppressing function.
In conclusion, the complex multi-step process of tumour The detection of T19 mRNA expression in all normal and neoplastic endometria examined, with~half of the neoplastic development involves many molecular genetic changes that result in the aberrant expression or loss of expression of genes samples expressing higher levels of T19 mRNA when compared with the normal endometria, suggests that the overinvolved in the maintenance of normal cell function. Few of the genes involved in progression of endometrial tumourogenexpression of T19 mRNA may be a common event in endometrial tumourogenesis. It is not known, however, whether the esis have been identified. The elucidation of these genes and their putative protein products may not only aid in the early observed increase in T19 mRNA relative abundance is the result of increased transcription or increased mRNA stability diagnosis and treatment of the disease but they may also be useful targets in future treatment therapies specific to carcinoma in the endometrial carcinomas. It is difficult to establish whether the change in T19 mRNA expression is a fundamental of the endometrium. While it is tempting to speculate that N22 may have potential tumour suppressor functions and T19 may part of the many molecular genetic alterations which presumably contribute to the progression of endometrial carcinoma, have oncogenic properties, it remains to be determined whether the changes in expression observed for these genes are a or whether it arises as a consequence of these changes. The partial sequence characterization of T19 has revealed a partial fundamental part of the many molecular genetic alterations which presumably contribute to the progression of endometrial sequence identity (at the nucleotide level) with a growth factor responsive gene expressed in vascular smooth muscle cells carcinoma, or whether they arise as a consequence of these changes. Future mRNA and protein sequence characterization (SM-20) isolated from Rattus norvegicus (Wax et al., 1994 (Wax et al., , 1996 . Transcription of the SM-20 gene is an immediate/early may help to clarify the function of N22 and T19 to confirm their true role in endometrial tumour development. response gene that may be induced in smooth muscle aorta
